Ahmed, S., Kanakry, J., Ahn, K., Litovich, C., Abdel-Azim, H., Aljurf, M., . . . Hamadani, M. (2019). Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide Based Haploidentical versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma.
Citación estilo ChicagoAhmed, S., et al. Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide Based Haploidentical Versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma. 2019.
Cita MLAAhmed, S., et al. Lower Graft-versus-Host Disease and Relapse Risk in Post-Transplant Cyclophosphamide Based Haploidentical Versus Matched Sibling Donor Reduced-Intensity Conditioning Transplant for Hodgkin Lymphoma. 2019.